NEW YORK (GenomeWeb) – MDxHealth today reported preliminary earnings for 2015 showing it has met its guidance for revenue and test volume.

The multinational healthcare company said it expects 2015 revenue of $16 million to $20 million, and 15,000 to 17,000 tests performed during the year. In Q4, the firm's ConfirmMDx prostate cancer test volume increased approximately 50 percent compared to the year-ago quarter, to more than 5,000 tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.